Repaglinide and gliclazide are equally effective when combined with bedtime insulin in patients with type 2 diabetes mellitus

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1419, 2004-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus

By Simons W. Robert   Hagan Michael A.  

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 765-780

Adis International

Access to resources Recommend Favorite

Administration of insulin aspart plus insulin protamine aspart two or three times daily is effective in patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1644, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Repaglinide: A Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus

By Plosker G.L.   Figgitt D.P.  

PharmacoEconomics, Vol. 22, Iss. 6, 2004-01 ,pp. : 389-411

Adis International

Access to resources Recommend Favorite

Defining the Role of Repaglinide in the Management of Type 2 Diabetes Mellitus: A Review

By Odd Erik Johansen  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 5, 2007-01 ,pp. : 319-335

Adis International

Access to resources Recommend Favorite

Repaglinide: A Review of its Therapeutic Use in Type 2 Diabetes Mellitus

By Culy C.R.   Jarvis B.  

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1625-1660

Adis International

Access to resources Recommend Favorite